Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RemImazolam Besylate for ICU-sedation in Patients With Mechanical Ventilation After Oral and Maxillofacial Surgery: Multicenter, Randomized, Non-inferiority Clinical Study

NCT05606315 is registered in ClinicalTrials.gov with Nanfang Hospital, Southern Medical University as lead sponsor.

NCT NCT05606315
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05606315 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RemImazolam Besylate for ICU-sedation in Patients With Mechanical Ventilation After Oral and Maxillofacial Surgery: Multicenter, Randomized, Non-inferiority Clinical Study
Lead sponsor
Nanfang Hospital, Southern Medical University
Phase
Phase 4
Overall status
Terminated
Start date
March 16, 2022
Completion date
February 9, 2025
Enrollment
117 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

icu, remimazolam besylate, sedation